(IN BRIEF) Amadix, a Spanish biotech company focused on non-invasive blood tests for early cancer detection, has secured a €15 million loan from the European Investment Bank (EIB). This funding, backed by InvestEU, will support Amadix in advancing its blood … Read the full press release →
Posted in Banks, Business, Economy, Environment, Financial, Healthcare, Industrial, Investment, Luxembourg, Management, News, Science, Spain, Technology
Tagged AI, Amadix, artificial intelligence, colorectal cancer, DiagnoLung, digitalization, early cancer detection, Early Detection, EIB, EU Beating Cancer Plan, European Investment Bank, European medtech startups, InvestEU, life sciences, liquid biopsy, miRNAs, non-invasive blood tests, PancreaDix, partnership, PreveCol, protein analysis, Rocío Arroyo, sustainability, technological innovation, U.S. market, Valladolid, €15 million loan